Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Managing Side Effects of HIV TreatmentManaging Side Effects of HIV Treatment
          
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Does ANY lipodystrophy or lipoatrophy develop from PEP course?
Jan 26, 2011

I am currently on a 28 day course of combivir and kaletra. Has there been ANY reported cases at all of any level of lipoatrophy and/or liposystrophy from this short term PEP treatment?

I started today and am nervous about the gastrointestinal side effects as I heard they can be quite severe in people. But I'm most concerned about any lipodystrphy and lipoatrophy as that also seems progressive and irreversible once it starts.

Thanks so much for all you guys do on the site!

Response from Dr. Henry

Significant lipodystrophy from a 28 day course of Kaletra/Combivir is extremely unlikely to occur-I have not observed it nor am I aware of any published well documented case. Also, mild/early lipodystrophy is often stabilized or reversed when the offending drugs are stopped. KH



Previous
TRUVADA-REYATAZ-NORVIR
Next
Reducing Dose Of Truvada?

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement